Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ryuta Koishi is active.

Publication


Featured researches published by Ryuta Koishi.


Nature Genetics | 2002

Angptl3 regulates lipid metabolism in mice

Ryuta Koishi; Yosuke Ando; Mitsuru Ono; Mitsuru Shimamura; Hiroaki Yasumo; Toshihiko Fujiwara; Hiroyoshi Horikoshi; Hidehiko Furukawa

The KK obese mouse is moderately obese and has abnormally high levels of plasma insulin (hyperinsulinemia), glucose (hyperglycemia) and lipids (hyperlipidemia). In one strain (KK/San), we observed abnormally low plasma lipid levels (hypolipidemia). This mutant phenotype is inherited recessively as a mendelian trait. Here we report the mapping of the hypolipidemia (hypl) locus to the middle of chromosome 4 and positional cloning of the autosomal recessive mutation responsible for the hypolipidemia. The hypl locus encodes a unique angiopoietin-like lipoprotein modulator, which we named Allm1. It is identical to angiopoietin-like protein 3, encoded by Angptl3, and has a highly conserved counterpart in humans. Overexpression of Angptl3 or intravenous injection of the purified protein in KK/San mice elicited an increase in circulating plasma lipid levels. This increase was also observed in C57BL/6J normal mice. Taken together, these data suggest that Angptl3 regulates lipid metabolism in animals.


Clinical Pharmacology & Therapeutics | 2003

A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus

Ichiro Watanabe; Aiko Tomita; Miho Shimizu; Mie Sugawara; Hiroaki Yasumo; Ryuta Koishi; Tohru Takahashi; Kaoru Miyoshi; Takashi Izumi; Yasuyuki Matsushita; Hidehiko Furukawa; Hideyuki Haruyama; Teiichiro Koga

Troglitazone is a 2,4‐thiazolidinedione antidiabetic agent with insulin‐sensitizing activities. This agent had been used efficiently in a large number of patients but was withdrawn from the market in March 2000 because of its association with idiosyncratic hepatotoxicity. To address the susceptible genetic factors responsible for the hepatotoxicity associated with this agent, we performed a genetic polymorphic analysis by a target gene approach in troglitazone‐treated Japanese patients with type 2 diabetes mellitus.


Journal of Biological Chemistry | 2004

A Superfamily of Voltage-gated Sodium Channels in Bacteria

Ryuta Koishi; Haoxing Xu; Dejian Ren; Betsy Navarro; Benjamin W. Spiller; Qing Shi; David E. Clapham

NaChBac, a six-α-helical transmembrane-spanning protein cloned from Bacillus halodurans, is the first functionally characterized bacterial voltage-gated Na+-selective channel (Ren, D., Navarro, B., Xu, H., Yue, L., Shi, Q., and Clapham, D. E. (2001) Science 294, 2372-2375). As a highly expressing ion channel protein, NaChBac is an ideal candidate for high resolution structural determination and structure-function studies. The biological role of NaChBac, however, is still unknown. In this report, another 11 structurally related bacterial proteins are described. Two of these functionally expressed as voltage-dependent Na+ channels (NaVPZ from Paracoccus zeaxanthinifaciens and NaVSP from Silicibacter pomeroyi). NaVPZ and NaVSP share ∼40% amino acid sequence identity with NaChBac. When expressed in mammalian cell lines, both NaVPZ and NaVSP were Na+-selective and voltage-dependent. However, their kinetics and voltage dependence differ significantly. These single six-α-helical transmembrane-spanning subunits constitute a widely distributed superfamily (NaVBac) of channels in bacteria, implying a fundamental prokaryotic function. The degree of sequence homology (22-54%) is optimal for future comparisons of NaVBac structure and function of similarity and dissimilarity among NaVBac proteins. Thus, the NaVBac superfamily is fertile ground for crystallographic, electrophysiological, and microbiological studies.


Journal of Biological Chemistry | 1997

CLONING AND CHARACTERIZATION OF A NOVEL OXIDOREDUCTASE KDRF FROM A HUMAN BONE MARROW-DERIVED STROMAL CELL LINE KM-102

Ryuta Koishi; Ichiro Kawashima; Chigusa Yoshimura; Mie Sugawara

A cDNA clone coding for a novel oxidoreductase was cloned from a human bone marrow-derived stromal cell line KM-102. We screened a cDNA library constructed from the mRNA of KM-102 cells stimulated with phorbol 12-myristate 13-acetate and calcium ionophore A23187 using a 32P-labeled 15-mer synthetic oligonucleotide (5′-TAAATAAATAAATAA-3′) probe. This probe was designed as a complementary sequence to the three reiterated AUUUA sequences, which are contained in the 3′-untranslated regions of cytokine and some proto-oncogene mRNAs and correlate with rapid mRNA turnover. Then, we obtained one cDNA clone, and further sequence analysis revealed that it coded for a new protein exhibiting 30 to ∼40% homology with glutathione reductase. By fusion protein analysis, this protein showed reducing activities on 2,6-dichlorophenol-indophenol and 5,5′-dithio-bis(2-nitrobenzoic acid) but only a weak reducing activity on oxidized glutathione. Although it lacked a stretch of hydrophobic amino acids in its N terminus, it was secreted by monkey kidney-derived COS-1 cells when we introduced the expression plasmid into them and also secreted by a human lung carcinoma cell line A549. Northern blot analysis revealed that the mRNA turnover of this protein was regulated by inflammatory stimuli in KM-102 cells. These results show that this protein may have scavenging enzyme properties and has its mRNA expression regulated in a similar fashion to cytokine genes or proto-oncogenes. Thus, we named it KDRF (KM-102-erived eductase-like actor), and KDRF may play a role in scavenging reactive oxygen intermediates, which are possibly toxic to cells, in response to inflammatory stimuli.


Journal of Biological Chemistry | 2002

ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.

Tetsuya Shimizugawa; Mitsuru Ono; Mitsuru Shimamura; Kenichi Yoshida; Yosuke Ando; Ryuta Koishi; Kenjiro Ueda; Toshimori Inaba; Hiroyuki Minekura; Takafumi Kohama; Hidehiko Furukawa


Journal of Biological Chemistry | 2003

Protein Region Important for Regulation of Lipid Metabolism in Angiopoietin-like 3 (ANGPTL3) ANGPTL3 IS CLEAVED AND ACTIVATED IN VIVO

Mitsuru Ono; Tetsuya Shimizugawa; Mitsuru Shimamura; Kenichi Yoshida; Chisa Noji-Sakikawa; Yosuke Ando; Ryuta Koishi; Hidehiko Furukawa


Journal of Biological Chemistry | 2003

Angiopoietin-like Protein 3 Mediates Hypertriglyceridemia Induced by the Liver X Receptor

Toshimori Inaba; Morihiro Matsuda; Mitsuru Shimamura; Norihide Takei; Naoki Terasaka; Yosuke Ando; Hiroaki Yasumo; Ryuta Koishi; Makoto Makishima; Iichiro Shimomura


Journal of Lipid Research | 2003

A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice

Yosuke Ando; Tetsuya Shimizugawa; Shigehito Takeshita; Mitsuru Ono; Mitsuru Shimamura; Ryuta Koishi; Hidehiko Furukawa


Experimental Animals | 2006

Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity.

Kazunori Fujimoto; Ryuta Koishi; Tetsuya Shimizugawa; Yosuke Ando


Biochemical and Biophysical Research Communications | 2004

Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor.

Mitsuru Shimamura; Morihiro Matsuda; Yosuke Ando; Ryuta Koishi; Hiroaki Yasumo; Hidehiko Furukawa; Iichiro Shimomura

Collaboration


Dive into the Ryuta Koishi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takafumi Kohama

Georgetown University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tohru Takahashi

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge